Mechanisms of neurodevelopmental toxicity of topiramate
- PMID: 38995641
- PMCID: PMC11296906
- DOI: 10.1080/10408444.2024.2368552
Mechanisms of neurodevelopmental toxicity of topiramate
Abstract
Prescriptions for antiseizure medications (ASMs) have been rapidly growing over the last several decades due, in part, to an expanding list of clinical indications for which they are now prescribed. This trend has raised concern for potential adverse neurodevelopmental outcomes in ASM-exposed pregnancies. Recent large scale population studies have suggested that the use of topiramate (TOPAMAX, Janssen-Cilag), when prescribed for seizure control, migraines, and/or weight management, is associated with an increased risk for autism spectrum disorder (ASD), intellectual disability, and attention-deficit/hyperactivity disorder (ADHD) in exposed offspring. Here, we critically review epidemiologic evidence demonstrating the neurobehavioral teratogenicity of topiramate and speculate on the neuromolecular mechanisms by which prenatal exposure may perturb neurocognitive development. Specifically, we explore the potential role of topiramate's pharmacological interactions with ligand- and voltage-gated ion channels, especially GABAergic signaling, its effects on DNA methylation and histone acetylation, whether topiramate induces oxidative stress, and its association with fetal growth restriction as possible mechanisms contributing to neurodevelopmental toxicity. Resolving this biology will be necessary to reduce the risk of adverse pregnancy outcomes caused by topiramate or other ASMs.
Keywords: ADHD; Topiramate; antiseizure medications; autism spectrum disorder; intellectual disability; neurodevelopment; neurodevelopmental toxicity.
Conflict of interest statement
JWS and VK performed research of scientific literature and drafted the article. JWS, VK, and RHF conceptualized the article and contributed critical revision of editorial and scientific content. RHF has provided litigation consulting services and was formerly associated with TeratOmic Consulting, a now defunct organization. He also received travel funds to attend editorial board meetings for the Journal of Reproductive and Developmental Medicine.
Similar articles
-
Neurodevelopmental and Functional Outcomes Following In Utero Exposure to Antiseizure Medication: A Systematic Review.Neurology. 2024 Apr 23;102(8):e209175. doi: 10.1212/WNL.0000000000209175. Epub 2024 Mar 26. Neurology. 2024. PMID: 38531021
-
Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability.JAMA Neurol. 2022 Jul 1;79(7):672-681. doi: 10.1001/jamaneurol.2022.1269. JAMA Neurol. 2022. PMID: 35639399
-
Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.N Engl J Med. 2024 Mar 21;390(12):1069-1079. doi: 10.1056/NEJMoa2309359. N Engl J Med. 2024. PMID: 38507750 Free PMC article.
-
Annual Research Review: Maternal antidepressant use during pregnancy and offspring neurodevelopmental problems - a critical review and recommendations for future research.J Child Psychol Psychiatry. 2019 Apr;60(4):356-376. doi: 10.1111/jcpp.13004. Epub 2018 Dec 5. J Child Psychol Psychiatry. 2019. PMID: 30515808 Free PMC article. Review.
-
Gestational exposure to benzodiazepines or z-hypnotics and neurodevelopmental disorders in offspring: Systematic review and meta-analysis.Acta Psychiatr Scand. 2024 Aug;150(2):65-77. doi: 10.1111/acps.13696. Epub 2024 May 15. Acta Psychiatr Scand. 2024. PMID: 38751163 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources